- Home
- RCEL vs EFTY Comparison
RCEL vs EFTY Comparison
Compare RCEL & EFTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCEL
- EFTY
- Stock Information
- Founded
- RCEL N/A
- EFTY 2013
- Country
- RCEL United States
- EFTY Hong Kong
- Employees
- RCEL N/A
- EFTY N/A
- Industry
- RCEL Medical/Dental Instruments
- EFTY
- Sector
- RCEL Health Care
- EFTY
- Exchange
- RCEL Nasdaq
- EFTY Nasdaq
- Market Cap
- RCEL 113.7M
- EFTY 113.6M
- IPO Year
- RCEL N/A
- EFTY 2025
- Fundamental
- Price
- RCEL $4.56
- EFTY $8.07
- Analyst Decision
- RCEL Strong Buy
- EFTY
- Analyst Count
- RCEL 4
- EFTY 0
- Target Price
- RCEL $13.75
- EFTY N/A
- AVG Volume (30 Days)
- RCEL 282.4K
- EFTY 363.5K
- Earning Date
- RCEL 11-06-2025
- EFTY 01-01-0001
- Dividend Yield
- RCEL N/A
- EFTY N/A
- EPS Growth
- RCEL N/A
- EFTY N/A
- EPS
- RCEL N/A
- EFTY 0.05
- Revenue
- RCEL $74,884,000.00
- EFTY $2,525,909.00
- Revenue This Year
- RCEL $28.23
- EFTY N/A
- Revenue Next Year
- RCEL $35.24
- EFTY N/A
- P/E Ratio
- RCEL N/A
- EFTY $171.00
- Revenue Growth
- RCEL 38.32
- EFTY 3855.20
- 52 Week Low
- RCEL $3.60
- EFTY $3.88
- 52 Week High
- RCEL $14.16
- EFTY $8.68
- Technical
- Relative Strength Index (RSI)
- RCEL 46.58
- EFTY N/A
- Support Level
- RCEL $4.12
- EFTY N/A
- Resistance Level
- RCEL $4.44
- EFTY N/A
- Average True Range (ATR)
- RCEL 0.25
- EFTY 0.00
- MACD
- RCEL 0.03
- EFTY 0.00
- Stochastic Oscillator
- RCEL 50.00
- EFTY 0.00
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
About EFTY Etoiles Capital Group Co. Ltd. Class A Ordinary Shares
Etoiles Capital Group Co Ltd specializes in providing integrated investor relations services within the financial industry.